Drug · DIN 02459612
BAT
BOTULISM ANTITOXIN HEPTAVALENT (A, B, C, D, E, F, G) - (EQUINE)
Restricted access only
Authorized for restricted access only.
Status Restricted Access since October 25, 2017.
- Drug Identification Number (DIN)
- 02459612
- Company (DIN owner)
- Emergent Biosolutions Canada IncWinnipeg, Manitoba, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Botulinum antitoxin J06AA04
- Class
- Human
- Record last updated
- November 28, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BOTULINUM ANTITOXIN SEROTYPE A | 4500 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE B | 3300 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE C | 3000 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE D | 600 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE E | 5100 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE F | 3000 UNIT | VIAL |
| BOTULINUM ANTITOXIN SEROTYPE G | 600 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 9, 2017: NOC 19281New Drug Submission (NDS) · Manufacturer name change
- December 8, 2016: NOC 18737New Drug Submission (NDS)